ÂÜÀòÂÒÂ×

Anthony Aiudi is an accomplished investor and board member with extensive experience in various organizations, including Morningside Technology Advisory LLC as an Investor since January 2020 and serving in multiple board roles across companies such as AdvanCell Isotopes Pty Ltd, Neutrolis Inc, and Fount Bio, Inc. Currently, Anthony holds the position of President at Evantigen, Inc. Anthony's educational background includes a Doctor of Pharmacy (PharmD) and an M.B.A. from the University of Rhode Island, as well as a Master of Science in Finance from Northeastern University.